Live Breaking News & Updates on Harmony biosciences holdings

Stay informed with the latest breaking news from Harmony biosciences holdings on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Harmony biosciences holdings and stay connected to the pulse of your community

Harmony Biosciences Stock Gains 10% On Q1 Results

Harmony Biosciences Stock Gains 10% On Q1 Results
rttnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rttnews.com Daily Mail and Mail on Sunday newspapers.

Nasdaq , Thomson-reuters , Harmony-biosciences-holdings-inc , Harmony-biosciences-holdings ,

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $40.63 Consensus PT from Analysts

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight research firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating and six have assigned a buy rating to the company. The average 12-month price […]

Los-angeles , California , United-states , America , Jeffrey-dierks , Prairiewood-capital , Allspring-global-investments-holdings , Goldman-sachs-group , Needham-company , Harmony-biosciences-company-profile , Cantor-fitzgerald , Los-angeles-capital-management

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of "Moderate Buy" by Analysts

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating and six have assigned a buy rating to the company. The average 12 month target […]

United-states , America , Jeffrey-dierks , Needham-company , Harmony-biosciences-holdings-inc , Vanguard-group-inc , Harmony-biosciences-company-profile , Goldman-sachs-group , Nasdaq , Cantor-fitzgerald , Pacer-advisors-inc , Hermes-inc

Harmony Biosciences (NASDAQ:HRMY) Sees Large Volume Increase

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) shares saw strong trading volume on Monday . 362,007 shares traded hands during trading, a decline of 1% from the previous session’s volume of 363,865 shares.The stock last traded at $29.98 and had previously closed at $30.65. Wall Street Analysts Forecast Growth A number of equities […]

United-states , America , Jeffrey-dierks , Acadian-asset-management , Jpmorgan-chase-co , Nasdaq , Cantor-fitzgerald , Citigroup-inc , Harmony-biosciences-holdings-inc , Goldman-sachs-group , Metlife-investment-management , York-mellon-corp

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $41.00 Average Target Price from Brokerages

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $41.00 Average Target Price from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Jeffrey-dierks , Manufacturers-life-insurance-company , Exchange-traded-concepts , Quadrant-capital-group , Cantor-fitzgerald , Needham-company , Goldman-sachs-group , Nasdaq , Pricet-rowe-associates-inc , Harmony-biosciences-company-profile

Harmony Biosciences (HRMY) Commences Phase 3 TEMPO Study

Harmony Biosciences (HRMY) Commences Phase 3 TEMPO Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kumar-budur , Harmony-biosciences-holdings-inc , Us-food-drug-administration , Harmony-biosciences-holdings , Drug-administration , Orphan-drug-designation , Chief-medical-officer ,

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming...

Miami , Florida , United-states , Luis-sanay , Paragon-biosciences , Nasdaq , Harmony-biosciences-holdings-inc , Barclays , Harmony-biosciences-holdings , Partners-global-biopharma-conference , Annual-global-healthcare , Harmony-biosciences

Harmony Biosciences (NASDAQ:HRMY) Trading Down 5.8% Following Weak Earnings

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) traded down 5.8% during mid-day trading on Thursday following a dissappointing earnings announcement. The company traded as low as $29.51 and last traded at $31.08. 327,111 shares were traded during mid-day trading, an increase of 1% from the average session volume of 324,257 shares. The stock […]

China , United-states , Raymond-james , Nasdaq , Lazard-asset-management , Harmony-biosciences-holdings-inc , China-universal-asset-management-co , Life-insurance-co , Goldman-sachs-group , Cantor-fitzgerald , Quadrant-capital-group , Wealth-partners

Harmony Biosciences (NASDAQ:HRMY) Trading Down 5.8% After Earnings Miss

Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) fell 5.8% during mid-day trading on Thursday following a weaker than expected earnings announcement. The company traded as low as $29.51 and last traded at $31.08. 327,111 shares were traded during mid-day trading, an increase of 1% from the average session volume of 324,257 […]

United-states , China , America , Raymond-james , Harmony-biosciences-holdings-inc , China-universal-asset-management-co , Nasdaq , Harmony-biosciences-company-profile , Lazard-asset-management , Wealth-partners , Quadrant-capital-group , Cantor-fitzgerald

Harmony Biosciences (NASDAQ:HRMY) Shares Down 5.8% on Disappointing Earnings

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) shares traded down 5.8% during trading on Thursday following a dissappointing earnings announcement. The stock traded as low as $29.51 and last traded at $31.08. 327,111 shares traded hands during trading, an increase of 1% from the average session volume of 324,257 shares. The stock had […]

China , United-states , America , Lazard-asset-management , Life-insurance-co , Needham-company , Harmony-biosciences-holdings-inc , Nasdaq , Goldman-sachs-group , Wealth-partners , Cantor-fitzgerald